Improving generalizability of drug–target binding prediction by pre-trained multi-view molecular representations
Bioinformatics · 26.12.2024 · 41 (1)
DOI: 10.1093/bioinformatics/btaf002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformatics, online erschienen am 07.01.2025. Verfasst von Xike Ouyang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Information Science and Technology, Institute of Computational Biology, Northeast Normal University, Changchun, Jilin 130117, China. Hauptthemen laut MEDLINE: Neural Networks, Computer, Computational Biology, Drug Discovery, Proteins. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jilin Scientific and Technological Development Program, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Motivation Most drugs start on their journey inside the body by binding the right target proteins. This is the reason that numerous efforts have been devoted to predicting the drug–target binding during drug development. However, the inherent diversity among molecular properties, coupled with limited training data availability, poses challenges to the accuracy and generalizability of these methods beyond their training domain. Results In this work, we proposed a neural networks construction for high accurate and generalizable drug–target binding prediction, named Pre-trained Multi-view Molecular Representations (PMMR). The method uses pre-trained models to transfer representations of target proteins and drugs to the domain of drug–target binding prediction, mitigating the issue of poor generalizability stemming from limited data. Then, two typical representations of drug molecules, Graphs and SMILES strings, are learned respectively by a Graph Neural Network and a Transformer to achieve complementarity between local and global features. PMMR was evaluated on drug–target affinity and interaction benchmark datasets, and it derived preponderant performance contrast to peer methods, especially generalizability in cold-start scenarios. Furthermore, our state-of-the-art method was indicated to have the potential for drug discovery by a case study of cyclin-dependent kinase 2. Availability and implementation https://github.com/NENUBioCompute/PMMR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Information Science and Technology, Institute of Computational Biology, Northeast Normal University, Changchun, Jilin 130117, China.
- School of Computer Science and Engineering, Changchun University of Technology, Changchun, Jilin 130051, China.
ORCID-Profile: Xike Ouyang, Han Wang
Förderung
- National Natural Science Foundation of China
- Jilin Scientific and Technological Development Program
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Ouyang, X., Feng, Y., Cui, C., Li, Y., Zhang, L., & Wang, H. (2024). Improving generalizability of drug–target binding prediction by pre-trained multi-view molecular representations. Bioinformatics, 41(1). https://doi.org/10.1093/bioinformatics/btaf002
Vancouver
Ouyang X, Feng Y, Cui C, Li Y, Zhang L, Wang H. Improving generalizability of drug–target binding prediction by pre-trained multi-view molecular representations. Bioinformatics. 2024;41(1). doi:10.1093/bioinformatics/btaf002
BibTeX
@article{Ouyang2024,
author = {Ouyang, Xike and Feng, Yannuo and Cui, Chen and Li, Yunhe and Zhang, Li and Wang, Han},
title = {Improving generalizability of drug–target binding prediction by pre-trained multi-view molecular representations},
journal = {Bioinformatics},
year = {2024},
volume = {41},
number = {1},
doi = {10.1093/bioinformatics/btaf002}
}
EUVIMED